Monogram Orthopaedics, Inc.

As of June 9, 2025, the trend is mildly bullish due to positive indicators like the MACD and Bollinger Bands, but caution is advised due to mixed signals in longer time frames.

Monogram Orthopaedics, Inc. is a micro-cap company in the Pharmaceuticals & Biotechnology industry, currently reporting a net profit loss of $3 million and a market cap of $98.82 million. Key financial metrics include a P/E ratio of NA, a dividend yield of 0.00%, and a return on equity of -136.96%.

As of Jun 18, Monogram Orthopaedics, Inc. has a market capitalization of 98.82 million, with net sales of 0.00 million and a net profit of -16.01 million over the latest four quarters. The company reported shareholder's funds of 14.50 million and total assets of 17.77 million as of Dec 24.